NASDAQ$KALA

Kala Bio Inc · Q4 2015 earnings

Q4 2015 earnings · · Investor relations

Headline financials

EPS (adj)

-$10.16

No prior period
Net Income

-$4.92M

No prior period
Operating Income

-$4.97M

No prior period
Gross Profit

-$95K

No prior period
R&D Expense

$3.83M

No prior period

Revenue & EPS history

Kala Bio · Revenue · Quarterly

$0

Q3 2025
Beat estimate in 1 of 5 quarters(20%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

+1.5%

Avg return

Earnings day

+0.1%

Avg return

5 days after

-4.7%

Avg return

30 days after

40%

14 / 35 earnings

Positive

+119.7%

Q4 2022

Best reaction

-18.3%

Q1 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-1.6%-17.4%-17.7%
Q3 2025-7.4%-10.4%-9.7%
Q2 2025+2.0%+9.9%+103.2%
Q1 2025-5.0%+4.6%+23.6%
Q4 2024-1.5%+1.5%+0.0%
Q3 2024-6.1%-9.5%-17.7%
Q2 2024+3.2%-1.7%-1.7%
Q1 2024-0.9%-3.9%-12.0%
Q4 2023+0.3%-2.4%-21.0%
Q3 2023-6.6%-2.2%+19.7%
Q2 2023-6.5%-8.4%-7.9%
Q1 2023-2.8%+3.0%-5.3%
Q4 2022+119.7%+114.5%+48.0%
Q3 2022+23.7%+34.9%-1.9%
Q2 2022-3.4%-4.6%-1.7%
Q1 2022+8.2%-5.4%-43.1%
Q4 2021-16.6%-25.1%-61.9%
Q3 2021+4.3%-7.7%-30.4%
Q2 2021-6.3%-4.8%-2.7%
Q1 2021-18.3%-18.4%-9.0%
Q4 2020-17.0%-17.6%-21.4%
Q3 2020-1.8%+0.6%+2.5%
Q2 2020-2.7%-2.5%-13.2%
Q1 2020-2.8%+2.8%+17.0%
Q4 2019+3.5%+1.6%+1.3%
Q3 2019+7.0%-4.4%+4.2%
Q2 2019+1.2%-0.6%-20.6%
Q1 2019-8.6%-17.2%-24.2%
Q4 2018+1.0%+6.6%-1.6%
Q3 2018-5.4%-13.8%-25.9%
Q2 2018+1.6%-3.9%-8.5%
Q1 2018+2.0%+3.7%-16.0%
Q4 2017-7.1%-7.4%-7.4%
Q3 2017-3.6%+2.6%+1.7%
Q2 2017+5.4%+6.2%-3.7%
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro